MeVis Medical Solutions Aktie
| 25,20EUR | 0,60EUR | 2,44% |
WKN DE: A0LBFE / ISIN: DE000A0LBFE4
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 107 | 104 | 104 | 114 | 116 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,16 | 0,16 | 0,18 | 0,15 | 0,15 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 11 | 11 | 15 | 11 | 10 |
| Summe Anlagevermögen | 17 | 17 | 17 | 17 | 17 |
| Summe Aktiva | 28 | 28 | 31 | 28 | 26 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 10 | 10 | 13 | 10 | 9 |
| Summe Eigenkapital | 18 | 18 | 18 | 18 | 18 |
| Summe Passiva | 28 | 28 | 31 | 28 | 26 |
Adresse
| Caroline-Herschel-Straße 1, 28359 Bremen | |
| Telefon | +49 (421) 22495-0 |
| Fax | +49 (421) 22495-999 |
| Internet | http://mevis.de |
Management
|
Kimberley E. Honeysett
Chairman-Supervisory Board |
|
Marcus Kirchhoff
Chief Executive Officer |
|
Shubham Maheshwari
Vice Chairman-Supervisory Board |
|
Sunny S. Sanyal
Member-Supervisory Board |